Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 5, 2019
New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin TherapyChing-Chih Hu, Cheng-Hao Weng, Man-Chin Hua, et al.In Vivo (Athens, Greece)|June 28, 2017
Clinical Predictors for Neutrophil-to-Lymphocyte Ratio Changes in Patients with Chronic Hepatitis B Receiving Peginterferon TreatmentPuo-Hsien Le, Kung-Hao Liang, Ming-Ling Chang, et al.Cancer Cell International|June 21, 2025
HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progressionYang-Hsiang Lin, Ming-Wei Lai, Yu-De Chu, et al.International Journal of Molecular Sciences|October 27, 2022
The Mutation Hotspots at UGT1A Locus May Be Associated with Gilbert's Syndrome Affecting the Taiwanese PopulationPaul Wei-Che Hsu, Po-Cheng Liao, Yu-Hsiang Kao, et al.Journal of Clinical Gastroenterology|November 4, 2024
Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver CirrhosisTien-Shin Chou, Yuan Lin, Ming-Lung Tsai, et al.Hepatology (Baltimore, Md.)|August 25, 2023
Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosisWen-Juei Jeng, Rong-Nan Chien, Yi-Cheng Chen, et al.Clinical Therapeutics|April 26, 2022
Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in TaiwanChih-Lang Lin, Yi-Lan Lin, Kung-Hao Liang, et al.The Pharmacogenomics Journal|October 16, 2019
A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapyChen-Chun Lin, Chao-Wei Hsu, Yi-Cheng Chen, et al.Journal of Viral Hepatitis|February 11, 2020
Real-world experience of elbasvir/grazoprevir in Taiwan: This study was focused on liver and renal adverse effectsYi-Chung Hsieh, Chih-Lang Lin, Chao-Hung Hung, et al.World Journal of Surgical Oncology|January 28, 2012
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case reportChin-Ying Chien, Cheng-Cheng Hwang, Chun-Nan Yeh, et al.Pageof 12